, /PRNewswire/ -- The Shareholders Foundation, Inc. announced that a lawsuit was filed for certain investors in shares of SelectQuote, Inc. (NYSE: SLQT). Investors who purchased shares of SelectQuote, Inc. (NYSE: SLQT) prior to September 2020 and continue to hold any of thoseNYSE: SLQT shares also have certain options and should contact he Shareholders Foundation at [email protected] or call +1(858) 779 - 1554. On August 11, 2025, an investor inNYSE: SLQT shares filed a lawsuit against SelectQuote, Inc. ov ...

Core Points - Faruqi & Faruqi, LLP is investigating potential claims against SelectQuote, Inc. and reminds investors of the October 10, 2025 deadline to seek the role of lead plaintiff in a federal securities class action [2][3] Allegations Against SelectQuote - The complaint alleges that SelectQuote and its executives violated federal securities laws by making false and misleading statements, including directing Medicare beneficiaries to plans that compensated SelectQuote the most, rather than providing unbiased comparisons [4] - SelectQuote is accused of receiving illegal kickbacks from health insurance companies to steer Medicare beneficiaries towards certain plans, which led to non-compliance with applicable laws and regulations [4][5] - The U.S. Department of Justice filed a complaint against SelectQuote, alleging that from 2016 to at least 2021, the company received tens of millions of dollars in illegal kickbacks and engaged in discriminatory practices against less profitable beneficiaries [5] Stock Market Reaction - Following the DOJ's allegations, SelectQuote's stock price fell by $0.61, or 19.2%, closing at $2.56 per share on May 1, 2025, with unusually heavy trading volume [5]

NEW YORK, Oct. 10, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of SelectQuote, Inc. (NYSE: SLQT) between September 9, 2020 and May 1, 2025, both dates inclusive (the “Class Period”), of the important October 10, 2025 lead plaintiff deadline. SO WHAT: If you purchased SelectQuote securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. ...

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In SelectQuote (SLQT) To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in SelectQuote between September 9, 2020 and May 1, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. Click here to participate in the action. NEW YORK, Oct. 10, 2025 (GLOBE NEWSWIRE) -- What’s Happen ...

Core Viewpoint - SelectQuote Inc. is under increased legal scrutiny following a whistleblower lawsuit alleging deceptive sales practices, leading to a significant drop in its stock price and a subsequent class-action lawsuit from investors [1][4]. Legal Issues - The U.S. Department of Justice (DOJ) has intervened in a whistleblower lawsuit against SelectQuote, which claims the company engaged in misleading sales practices related to Medicare Advantage plans [1][3]. - The lawsuit, Pahlkotter v. SelectQuote Inc. et al., includes investors who purchased shares between September 9, 2020, and May 1, 2025, alleging that SelectQuote misrepresented its business model and regulatory risks [2][5]. Allegations of Misconduct - The complaint alleges that SelectQuote misrepresented its sales practices, claiming to provide "unbiased advice" while actually directing customers towards higher-commission plans and accepting illegal kickbacks [3][7]. - The DOJ's complaint indicates that from 2016 to at least 2021, SelectQuote received tens of millions of dollars in improper payments and discriminated against less profitable customers [3][7]. Market Reaction - Following the DOJ's involvement, SelectQuote's stock price fell nearly 20% in a single day, and shares have declined over 40% in the past six months due to investor concerns about legal exposure and reputational damage [4][5]. Investigative Actions - Hagens Berman, a shareholder rights firm, is investigating whether SelectQuote's revenue was artificially inflated through deceptive practices, transforming the situation into a serious federal matter [6].

Core Viewpoint - SelectQuote Inc. is under increased legal scrutiny due to a whistleblower lawsuit alleging deceptive sales practices, leading to a significant drop in its stock price and a subsequent class-action lawsuit from investors [1][5][6] Legal Issues - The U.S. Department of Justice (DOJ) has intervened in a lawsuit claiming SelectQuote engaged in misleading sales practices related to Medicare Advantage plans, resulting in improper payments and discrimination against less profitable customers [4][8] - The class-action lawsuit, Pahlkotter v. SelectQuote Inc. et al., includes investors who purchased shares between September 9, 2020, and May 1, 2025, alleging that the company misrepresented its business model and regulatory risks [2][6] Market Impact - Following the DOJ's involvement, SelectQuote's stock price fell nearly 20% on May 1, 2025, and has since declined over 40% in the past six months, reflecting investor concerns about legal exposure and reputational damage [5][6] Allegations of Misconduct - The lawsuit claims SelectQuote misrepresented its services as providing unbiased advice while allegedly steering customers towards higher-commission plans and accepting illegal kickbacks [4][8] - The DOJ's complaint indicates that SelectQuote's actions may have violated federal statutes, including the False Claims Act [8]

Core Viewpoint - A class action lawsuit has been filed against SelectQuote, Inc. for allegedly receiving illegal kickbacks from health insurance companies and misleading investors about its business practices [6]. Allegation Details - The U.S. Department of Justice filed a complaint against SelectQuote, alleging that from 2016 to at least 2021, the company received "tens of millions of dollars" in illegal kickbacks for steering Medicare beneficiaries to specific insurance plans [6]. - The lawsuit claims that SelectQuote made materially false statements regarding its services, asserting it provided unbiased coverage comparisons while actually directing beneficiaries to the most profitable plans for the company [6]. - Specific allegations include failure to disclose that SelectQuote did not provide unbiased comparisons, received illegal kickbacks, and was vulnerable to regulatory sanctions [6]. Stock Impact - Following the DOJ's announcement, SelectQuote's stock price dropped by $0.61, or 19.2%, closing at $2.56 per share on May 1, 2025, with unusually high trading volume [6]. Next Steps - Investors who purchased SelectQuote shares between September 9, 2020, and May 1, 2025, and suffered losses are encouraged to contact the law firm for more information and to discuss their legal rights [4][6]. - The deadline for investors to apply to be appointed as lead plaintiff in the lawsuit is October 10, 2025 [6].

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action lawsuit on behalf of purchasers and acquirers of SelectQuote, Inc. (NYSE: SLQT) securities between September 9, 2020 and May 1, 2025, both dates inclusive (the "Class Period†). SelectQuote is an insurance broker. For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investigating the Alleg. ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In SelectQuote To Contact Him Directly To Discuss Their Options If you suffered losses in SelectQuote between September 9, 2020 and May 1, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, L ...

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC ("KSF†) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until October 10, 2025 to file lead plaintiff applications in a securities class action lawsuit against SelectQuote, Inc. ("SelectQuote†or the "Company†) (NYSE: SLQT), if they purchased the Company's securities between September 9, 2020 and May 1, 2025, inclusive (the "Class Period†). This action is pending. ...